AI-Powered Pharma Hub to Create 50,000 Jobs in HyderabadAI-Powered Pharma Hub to Create 50,000 Jobs in Hyderabad An ambitious project led by the Hyderabad-based Pulsus Group aims to establish an AI-based Pharma Healthcare IT Hub in Ameenpur, Sangareddy. The hub, estimated to cost Rs 300 crore, is expected to create a significant impact on the healthcare and IT sectors, generating substantial economic benefits. Key Highlights: * 50,000 new jobs, including 10,000 direct and 40,000 indirect positions * Innovative AI applications in research, development, and healthcare delivery * Prime location within the IT/ITeS Zone in Ameenpur with excellent infrastructure and connectivity * Contribution to Hyderabad’s position as the “Bulk Drug Capital of India” and the “Vaccine Capital of the World” Economic Impact: The hub is expected to boost Telangana’s economy and strengthen its healthcare sector. Telangana currently ranks second in manufacturing and leads the country in per capita income. The AI-driven hub further solidifies the state’s position as a leader in innovation and inclusive growth. Contribution to the Healthcare Sector: The hub will leverage AI to enhance every aspect of the pharmaceutical industry, from drug development to patient care. This will drive advancements in medical research, improve healthcare outcomes, and create new opportunities for collaboration and innovation. Employment Opportunities: The project will generate substantial employment opportunities for the local population. The focus on AI and healthcare IT will attract skilled professionals from various fields, contributing to the development of a robust workforce in these sectors. Overall, the AI-based Pharma Healthcare IT Hub in Hyderabad is a significant undertaking that underscores the city’s commitment to innovation, economic growth, and the advancement of healthcare.
Hyderabad: An AI-based Pharma Healthcare IT Hub will create 50,000 jobs in Ameenpur, Sangareddy at an estimated cost of Rs 300 crore. Led by Hyderabad-based Pulsus Group, this ambitious project aims to have a significant impact on the healthcare and IT landscape and generate substantial economic benefits.
Dr. Srinubabu Gedela, CEO and Managing Director of Pulsus Group, announced the details of the project at the 73rd IPC Congress, an annual event for pharmacists, last Friday.
According to the Pulsus Group, the hub will create 10,000 direct jobs and 40,000 indirect jobs through supporting industries and services.
Key features of the project include innovative AI applications in all aspects of the pharmaceutical industry, from research and development to healthcare delivery.
The hub will generate significant employment opportunities for the local population. Located within the designated IT/ITeS Zone in Ameenpur, the hub benefits from exceptional infrastructure and connectivity, supported by the Telangana government and the Software Technology Parks of India.
Hyderabad’s pharmaceutical industry accounts for over 40% of India’s bulk drug production and is known as the ‘Bulk Drug Capital of India’ and the ‘Vaccine Capital of the World’.
The city’s innovation, infrastructure and inclusive growth have yielded significant results, with Telangana ranking second in manufacturing as per the Innovation Index-2022 and leading the country in per capita income by 2022-23. This AI-driven hub will significantly boost Telangana’s economy and healthcare sector, strengthening the state’s position.
This post was last modified on July 6, 2024 3:34 pm
